Elizabeth Crofts’ Post

Are you facing difficulties in scaling your drug from lab to market? Moving from clinical trials to full-scale production is often a major hurdle for small biotech companies. Lonza Small Molecules’ integrated CDMO services provide the expertise, technologies and flexibility to progress your product seamlessly through each development phase. Our global network and agile, collaborative approach ensures your production scales efficiently, while minimizing risks, to accelerate time to market. Read more about how Lonza Small Molecules can help you scale successfully: https://lnkd.in/gQUWgBMp

Are you facing difficulties in scaling your drug from lab to market? Moving from clinical trials to full-scale production is often a major hurdle for small biotech companies. Lonza Small Molecules’ integrated CDMO services provide the expertise, technologies and flexibility to progress your product seamlessly through each development phase. Our global network and agile, collaborative approach ensures your production scales efficiently, while minimizing risks, to accelerate time to market. Read more about how Lonza Small Molecules can help you scale successfully: https://lnkd.in/ewqxcUAk

Are you facing difficulties in scaling your drug from lab to market? Moving from clinical trials to full-scale production is often a major hurdle for small biotech companies. Lonza Small Molecules’ integrated CDMO services provide the expertise, technologies and flexibility to progress your product seamlessly through each development phase. Our global network and agile, collaborative approach ensures your production scales efficiently, while minimizing risks, to accelerate time to market. Read more about how Lonza Small Molecules can help you scale successfully: https://lnkd.in/eEzZmyJj

Lonza Small Molecules: 💡Did you know? 💡Did you know… that using a Powder-in-Capsule (PIC) approach can help accelerate your path into First-in-Human (FIH) studies? Transitioning to hashtag#FIH studies comes with many challenges: ensuring regulatory compliance, achieving a stable formulation, completing rigorous preclinical studies, securing funding—the list goes on. With Lonza's PIC technology, you can streamline and simplify the journey. 🎥 Watch the short video to learn more about how our PIC technology can help you navigate these complexities with ease and efficiency. 📚 Want to learn more? Access the full webinar to explore how our Micro-dosing Powder-in-Capsule Technology supports you at every step, from development to commercialization: https://bit.ly/40xY9sm #LonzaSM #WeWorkAsOne #SmallMolecules #Didyouknow

Lonza Small Molecules: 💡Did you know? 💡Did you know… that using a Powder-in-Capsule (PIC) approach can help accelerate your path into First-in-Human (FIH) studies? Transitioning to #FIH studies comes with many challenges: ensuring regulatory compliance, achieving a stable formulation, completing rigorous preclinical studies, securing funding—the list goes on. With Lonza's PIC technology, you can streamline and simplify the journey. 🎥 Watch the short video to learn more about how our PIC technology can help you navigate these complexities with ease and efficiency. 📚 Want to learn more? Access the full webinar to explore how our Micro-dosing Powder-in-Capsule Technology supports you at every step, from development to commercialization: https://bit.ly/40xY9sm #LonzaSM #WeWorkAsOne #SmallMolecules #Didyouknow

Lonza Small Molecules: 💡Did you know? 💡Did you know… that using a Powder-in-Capsule (PIC) approach can help accelerate your path into First-in-Human (FIH) studies? Transitioning to #FIH studies comes with many challenges: ensuring regulatory compliance, achieving a stable formulation, completing rigorous preclinical studies, securing funding—the list goes on. With Lonza's PIC technology, you can streamline and simplify the journey. 🎥 Watch the short video to learn more about how our PIC technology can help you navigate these complexities with ease and efficiency. 📚 Want to learn more? Access the full webinar to explore how our Micro-dosing Powder-in-Capsule Technology supports you at every step, from development to commercialization: https://bit.ly/40xY9sm #LonzaSM #WeWorkAsOne #SmallMolecules #Didyouknow

Lonza Small Molecules: 💡Did you know? 💡Did you know… that using a Powder-in-Capsule (PIC) approach can help accelerate your path into First-in-Human (FIH) studies? Transitioning to #FIH studies comes with many challenges: ensuring regulatory compliance, achieving a stable formulation, completing rigorous preclinical studies, securing funding—the list goes on. With Lonza's PIC technology, you can streamline and simplify the journey. 🎥 Watch the short video to learn more about how our PIC technology can help you navigate these complexities with ease and efficiency. 📚 Want to learn more? Access the full webinar to explore how our Micro-dosing Powder-in-Capsule Technology supports you at every step, from development to commercialization: https://lnkd.in/dznJzs57 #LonzaSM #WeWorkAsOne #SmallMolecules #Didyouknow

Early 2024 saw an uptick in dealmaking activity in the bio/pharma industry, and this momentum is likely to continue. What is attractive? Acquiring de-risked, quality assets that can uplift the innovation deficit and replenish revenue streams. TCG Labs Soleil is poised to deliver. Our model offers pharma and biotech with vetted assets ready for efficient adoption and development.  Learn more: https://lnkd.in/gCV9YAp5

🌐 Biotech moves fast—your production capabilities should, too. OcyonBio’s facilities are designed to adapt and scale with your needs, keeping you at the forefront of innovation. ⚙️ #ScalableSolutions #BiomanufacturingLeaders #OcyonBioEfficiency

With more novel specific therapies emerging, the need for smaller batch manufacturing is becoming more of a necessity. While specific challenges exist in large batch manufacturing, smaller batch production also comes with specific challenges. Check out this article from Emerson for key strategic areas to consider as your biopharmaceutical company evolves: https://hubs.ly/Q02Gy80z0 – #USPharma24 #GenerisPMOS #CDMOs #biopharma #Automation #smallbatchmanufacturing #batchproduction